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w Recognize that conditioning programs may need to be gender specific (see "The Team Physician and Conditioning of Athletes for Sports -A Consensus Statement" [2001] )
It is desirable the team physician:
w Identify proposed risk factors during the pre-participation evaluation w Coordinate a prevention program w Educate athletes, parents, coaches and other healthcare providers, including information about at-risk positions and game situations that are associated with ACL injury
THE FEMALE ATHLETE AND THE PATELLOFEMORAL JOINT
It is essential the team physician understand: w The anatomy and biomechanics of the patellofemoral joint w The mechanisms of patellofemoral pain and dysfunction
It is desirable the team physician:
w Coordinate the evaluation and treatment of athletes with patellofemoral problems w Understand the potential long-term sequelae of patellofemoral pain and dysfunction
Epidemiology
w Patellofemoral problems occur frequently in female athletes. w Patellofemoral pain and dysfunction result from macro-trauma and micro-trauma.
Physiology/Pathophysiology
w Normal patellofemoral mechanics involve a balance between bone alignment, articular cartilage, soft tissue (ligaments, muscles, tendons, fascia) and coordinated neuromuscular activation. w Patellofemoral pain and dysfunction are multi-factorial, including malalignment, articular cartilage lesions, instability, soft tissue factors and psychosocial issues. 
Evaluation and Treatment
It is essential the team physician: w Delineate key points relating to the history of the patellofemoral problem w Conduct a specific examination for the patellofemoral problem w Know the indications for and utility of imaging techniques w Understand non-operative management of patellofemoral problems, including patient education, activity modification, rehabilitation, bracing, orthoses and medications 
THE FEMALE ATHLETE AND SHOULDER CONDITIONS
It is essential the team physician understand: w The anatomy and biomechanics of the shoulder w The mechanisms of shoulder injury and dysfunction
It is desirable the team physician:
w Recognize that shoulder conditions may result from strength and flexibility imbalances or injuries elsewhere in the body w Identify risk factors associated with shoulder conditions w Coordinate the evaluation and treatment of shoulder conditions
Epidemiology
w Examples of high-risk sports include diving, gymnastics, swimming, tennis, throwing sports and volleyball. w Shoulder conditions result from macro-trauma and microtrauma. 
Physiology/Pathophysiology

THE FEMALE ATHLETE AND STRESS FRACTURES
It is essential the team physician understand: w A stress fracture in a female athlete can be an isolated injury, or may indicate underlying medical and psychosocial problems. Therefore, evaluation and treatment must take into account the etiology of the stress fracture. w Certain stress fractures are at high-risk for complications and long-term sequelae.
It is desirable the team physician:
w Coordinate, when necessary, multi-disciplinary evaluation and treatment
Epidemiology
w Stress fractures occur frequently in female athletes. w Some studies suggest a higher incidence of stress fractures in females, but there is little evidence to support a gender difference in stress fractures among trained athletes. w Common anatomical areas include the foot, tibia, fibula, femur and pelvis.
Physiology/Pathophysiology
w Stress fractures occur when bone is subjected to repetitive loads beyond its physiologic capacity. w An imbalance between bone resorption and deposition creates bone that may not withstand repetitive loads. 
Evaluation and Treatment
It is essential the team physician: w Delineate key points relating to the history of the stress fracture w Conduct a specific physical examination pertinent to the suspected stress fracture w Identify potential underlying risk factors w Know the indications for and utility of imaging techniques w Identify stress fractures at high-risk of complication and long-term sequelae w Know the indications for surgical consideration w Understand non-operative management and rehabilitation
It is desirable the team physician:
w Review the results of the imaging studies w Understand the principles of and indications for surgical management w Coordinate, when necessary, a multi-disciplinary team approach to treatment
Prevention
It is essential the team physician:
w Recognize there can be multiple risk factors for stress fractures
It is desirable the team physician:
w Recognize risk factors during the pre-participation evaluation w Implement a screening program for risk factors w Educate athletes, parents, coaches, administrators and healthcare providers
THE FEMALE ATHLETE AND OSTEOPENIA AND OSTEOPOROSIS
It is essential the team physician understand:
w Osteopenia and osteoporosis can exist in the young female athlete w These conditions have implications for athletic performance and long-term sequelae w Disordered eating and menstrual dysfunction are common risk factors
It is desirable the team physician understand:
w The evaluation and treatment of osteopenia and osteoporosis w The importance of educating athletes, parents, coaches, administrators and healthcare providers w The value of prevention and early detection of osteopenia and osteoporosis
Epidemiology
w The incidence of osteopenia and osteoporosis in the female athlete is unknown.
w Several studies have demonstrated osteopenia and osteoporosis in young female athletes with menstrual dysfunction and/or eating disorders. w The major determinant of adult bone mineral density (BMD) is bone mass achieved during adolescence and young adulthood. Osteoporosis-related fractures in later life are associated with significant morbidity and mortality.
Physiology/Pathophysiology
w Bone mass depends on the overall balance between resorption and deposition. w Ninety percent of total bone mineral content is accrued by the end of adolescence, creating a window of opportunity to maximize BMD. w Eighty percent of variance in BMD is attributed to genetic factors. Lean body mass, estrogen, exercise, and calcium intake are other important influences. w Tobacco use, excessive alcohol consumption, certain medical conditions (e.g., renal disease, hyperparathyroidism), and medications (e.g., glucocorticoids) can negatively affect bone density. w Athletes involved in impact sports and/or strength training routinely have higher site-specific BMD than athletes in nonimpact sports and non-athletes. 
Evaluation and Treatment
It is essential the team physician: w Recognize risk factors for low bone mineral density w Know the indications for and the utility of imaging techniques w Facilitate treatment for osteopenia and osteoporosis once identified
It is desirable the team physician:
w Understand criteria for osteopenia (one to 2.5 standard deviations [SD] below young adult mean BMD) and osteoporosis (greater than 2.5 SD below young adult mean BMD). w Coordinate a screening process to identify athletes at-risk w Coordinate a comprehensive evaluation including assessment of menstrual status and nutritional intake, measurement of BMD and laboratory testing as necessary w Understand that multi-disciplinary treatment may include restoration of normal menstrual cycles, optimization of physical activity and nutrition, psychological therapy, and pharmacological intervention.
Prevention
It is essential the team physician understand: w Optimal BMD is achieved by maintaining physiologic estrogen levels, adequate nutrition, and load-bearing exercise w The importance of prevention and early detection of osteopenia and osteoporosis
It is desirable the team physician:
w Identify risk factors during the pre-participation evaluation w Implement a screening program for risk factors, including information regarding strategies for maintaining optimal BMD and the effect of negative behaviors on BMD w Educate athletes, parents, coaches, administrators and healthcare professionals
THE FEMALE ATHLETE AND DISORDERED EATING
It is essential the team physician understand: w The importance of adequate nutrition in sports w The spectrum of disordered eating and how it affects the female athlete w Disordered eating can occur in any sport
It is desirable the team physician understand:
w The evaluation and treatment of the athlete with disordered eating w The importance of educating athletes, coaches, parents, administrators and other healthcare providers w The value of prevention and early detection of disordered eating
Epidemiology
w Disordered eating occurs on a spectrum. This ranges from calorie, protein and/or fat restriction and pathogenic weight control measures (e.g., diet pills, laxatives, excessive exercise, self-induced vomiting) to classic Eating Disorders, such as Anorexia Nervosa and Bulimia Nervosa. w Athletes in sports involving aesthetics, endurance and weight classifications are at particular risk for the spectrum of disordered eating. w Fifteen to 62 percent of college female athletes report a history of disordered eating. w Eating Disorders are psychiatric disorders with distortion of body image, significant nutritional and medical complications, including a mortality rate of 12 to 18 percent for untreated AN. w Female athletes are at higher risk for developing Eating Disorders than the general population. 
Physiology/Pathophysiology
Prevention
It is essential the team physician understand:
w The importance of prevention and early detection of the spectrum of disordered eating
It is desirable the team physician:
w Identify risk factors during the pre-participation evaluation w Implement a screening program for risk factors, including information to dispel misconceptions about body weight, body composition and athletic performance w Educate athletes, parents, coaches, administrators and healthcare providers
THE FEMALE ATHLETE AND SELECTED MENSTRUAL DYSFUNCTION
It is essential the team physician understand: w The normal menstrual cycle and the spectrum of menstrual dysfunction w The consequences of menstrual dysfunction on bone density and fertility
It is desirable the team physician understand:
w The evaluation and treatment of the athlete with menstrual dysfunction w The importance of educating athletes, parents, coaches, administrators and healthcare providers about menstrual dysfunction w The value of prevention and early detection of menstrual dysfunction Epidemiology w Menstrual dysfunction occurs in different forms: o Delayed menarche (onset of menstrual cycles after 16 years of age) o Secondary amenorrhea (absence of menses for three or more months after regular menses has been established) o Oligomenorrhea (six to nine cycles per year; cycle length greater than 35 days or less than three months) o Anovulation (absence of ovulation; may have regular menstrual bleeding) o Luteal phase deficiency (cycle length may be normal, but there are decreased progesterone levels) w In the athlete, menstrual dysfunction is at least two to three times more common than in the non-athlete; 10 to 15 percent have amenorrhea or oligomenorrhea.
Physiology/Pathophysiology
w Normal menstrual cycle depends on intact hypothalamicpituitary-ovarian (HPO) axis and normal pelvic organ function. w The etiology of menstrual dysfunction is multi-factorial, including body weight and body composition, nutrition, training, previous menstrual function and psychosocial factors. w The energy drain hypothesis states that energy expenditure exceeds stored and consumed energy, leading to disruption of the HPO axis. w Intense exercise alone does not necessarily cause menstrual dysfunction, provided there is adequate caloric intake for the energy needs. w Consequences of menstrual dysfunction may include lower levels of estrogen and/or progesterone, lower bone mineral density (BMD), higher incidence of stress fractures and infertility. w Effects of lower levels of estrogen on BMD are not completely reversible, therefore early detection and treatment of menstrual dysfunction is important.
Evaluation and Treatment
It is essential the team physician: w Understand menstrual dysfunction related solely to exercise is a diagnosis of exclusion w Recognize risk factors for and implications of menstrual dysfunction w Facilitate treatment of these conditions once identified, with a multi-disciplinary approach as necessary 
Physiology/Pathophysiology
w Physiological changes that may affect exercise throughout pregnancy include: o Musculoskeletal changes including weight gain o Medical changes including increased heart rate, cardiac output, blood volume, and respiratory rate w The goals of exercise throughout pregnancy are to maintain or improve pre-existing levels of maternal fitness without undue risk to the mother or the developing fetus. w Pregnancy increases nutritional needs for calories, iron, calcium and folic acid w Exercise in the supine position after 16 weeks should be avoided due to potential great vessel compression
Evaluation and Treatment
It is essential the team physician understand: w There are specific issues of the female athlete in terms of pregnancy and contraception
It is desirable the team physician:
w Facilitate obstetric care and treatment, including referral w Understand evaluation includes a medical examination, nutritional assessment and ongoing assessment of absolute and relative contraindications to exercise throughout pregnancy and the postpartum period. w Understand treatment may include the limitation of physical activity as pregnancy progresses and that discussion with others (i.e. healthcare providers, parents, coaches, and Certified Athletic Trainers) may be necessary.
